Investegate |NOVARTIS AG CHF0.50(REGD) Announcements | NOVARTIS AG CHF0.50(REGD): Novartis Cosentyx® (secukinumab) receives positive CHMP opinion for expanded use in childhood arthritic conditions

Investegate announcements from NOVARTIS AG CHF0.50(REGD), Novartis Cosentyx® (secukinumab) receives positive CHMP opinion for expanded use in childhood arthritic conditions

Related Keywords

Hamburg , Germany , Brazil , Japan , United States , America , Novartis Cosentyx , Isabella Zinck , Michael Meo , Thomas Hungerbuehler , Dermatol Venereol , Rachel Fink Thoma , Samir Shah , Parag Mahanti , Julie Masow , Todd Fox , Sloan Simpson , Ivan Foeldvari , Alina Levchuk , Twitter , Ministry Of Health , American College Of Rheumatology , Novartis , Novartis Europharm , Virtual Congress , Committee For Medicinal Products Human Use , Rheumatology Research Alliance Registry , Hamburg Centre For Pediatric Rheumatology , Novartis Us External Communications , European Alliance Of Associations , International League , Exchange Commission , Novartis Pharma Communications , European Medicines Agency , Novartis Pharmaceuticals Corp , Medicinal Products , Human Use , Hamburg Centre , Pediatric Rheumatology , Global Head , Medical Affairs Immunology , Provides Sustained Improvements , Psoriatic Arthritis , Pooled Safety , Enthesitis Related Arthritis , Juvenile Psoriatic Arthritis , Primary Results , Treatment Withdrawal , European Alliance , Associations For Rheumatology , Treatment In Children And Adolescents , Efficacy And Safety Results From , American College , Juvenile Arthritis , Childhood Arthritis , Rheumatology Research Alliance , Term Outcomes , Juvenile Idiopathic Arthritis , Eighteen Years , Arthritis Care Res , East Hanover , Extended Use , Investegate Announcements , Investegate Company Announcements , Ovartis Ag Chf0 50 Regd , Lobenewswire , Lobenewswire And Globenewswire , Nw ,